10 February 2022. SK Bioscience rolled out the first batch of Nuvaxovid, Novavax’s synthetic antigen-based COVID-19 vaccine. SK Bioscience has signed a contract with US bio firm to secure the manufacturing and supply rights in Korea, Thailand and Vietnam.https://www.nationthailand.com/international/40012150